FDA Approved: LONSURF — Supplemental Application (Taiho Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental application for LONSURF (trifluridine and tipiracil) from Taiho Pharmaceutical, expanding its regulatory coverage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)

Snippet

SUPPL AP for LONSURF (TRIFLURIDINE AND TIPIRACIL)